Exhibit 99.1

Herbalife Ltd. Announces Record Fourth Quarter 2013 and Record Full Year Results, and Raises 2014 Earnings Guidance

LOS ANGELES--(BUSINESS WIRE)--February 18, 2014--Herbalife Ltd. (NYSE: HLF) today reported fourth quarter net sales of $1.3 billion, reflecting an increase of 20 percent compared to the same period in 2012, on volume point growth of 13 percent. Net income for the quarter was $123.5 million, or $1.15 per diluted share. On an adjusted basis, adjusted1 net income for the quarter was $137.2 million, or $1.28 per diluted share, as compared to 2012 fourth quarter net income3 of $112.2 million and EPS of $1.00.

For the twelve months ended December 31, 2013, the company reported record net sales of $4.8 billion, an 18 percent increase, on 13 percent growth in volume compared to 2012. For the same period, the company reported net income of $527.5 million, or $4.91 per diluted share. On an adjusted basis, adjusted1 net income of $577.4 million, or $5.37 per diluted share, reflected increases of 24 percent and 36 percent respectively, over 2012 net income3 of $464.0 million and EPS of $3.94.

"Herbalife delivered another year of record financial performance achieved through the consistent execution of key strategies to expand daily consumption of our products," said Michael O. Johnson, Herbalife's chairman and CEO. "The global obesity epidemic continues to expand around the world, having an adverse impact on community health. Our independent Members are uniquely positioned, with education, coaching, and nutritious, industry-leading products to help their customers live healthier lives."

For the year ended December 31, 2013, Herbalife generated cash flow from operations of $772.9 million, an increase of 36 percent compared to 2012; paid dividends of $123.1 million; invested $162.5 million in capital expenditures; and repurchased $297.4 million in common shares outstanding under our previous share repurchase program.

Herbalife recently announced that the Board of Directors approved an increase in its share repurchase authorization to $1.5 billion. Following repurchases made in connection with the company’s recent financing transaction on February 7, 2014, the remaining authorized capacity under the repurchase program is $814 million.

Fourth Quarter and Fiscal 2013 Key Metrics4,5

Regional Volume Point and Average Active Sales Leader Metrics

         
  Volume Points (Mil)   Average Active Sales Leaders
Region   4Q'13   Yr/Yr % Chg   4Q'13   Yr/Yr % Chg
North America 287.0   7% 73,511   8%
Asia Pacific 292.4 -4% 73,792 6%
EMEA 183.9 17% 53,776 14%
Mexico 218.7 5% 66,535 8%
South & Central America 278.6 25% 65,690 29%
China   102.7   103%   17,416   39%
Worldwide Total   1,363.3   13%   339,744   13%
         
  Volume Points (Mil)   Average Active Sales Leaders
Region   FY 2013   Yr/Yr % Chg   FY 2013   Yr/Yr % Chg
North America 1,249.9   8% 72,058   9%
Asia Pacific 1,225.4 2% 71,542 13%
EMEA 698.0 16% 49,650 13%
Mexico 864.3 6% 63,581 10%
South & Central America 966.2 31% 58,090 29%
China   333.6   62%   14,808   27%
Worldwide Total   5,337.4   13%   318,740   15%

2013 Annual Sales Leader Requalification

By the end of January of each year, sales leaders are required to re-qualify to retain their sales leader status. A record number of sales leaders were retained in 2013. The overall pool of sales leaders needing to re-qualify increased by approximately 10% compared to the prior year and we retained 10% more of them than in the prior year. While size of the group needing to re-qualify increased for the year, our overall retention rate remained fairly constant at 51.8%.

2014 First Quarter and Full Year Guidance

Forward guidance excludes the impact of expenses (primarily for legal and advisory services) relating to the company's response to information put into the marketplace by a short seller, which information the company believes to be inaccurate and misleading, and the impact of non-cash interest costs associated with the company’s Convertible Notes. Forward guidance is based on the average daily exchange rates of the first two weeks of January. Included in the guidance is the use of the GAAP rate for Venezuela of 6.3 to 1 for January results and 10 to 1 for the balance of the year and excludes the potential impact of future devaluation of the Venezuelan bolivar and any future repatriation of existing cash balances in Venezuela.

  Three Months Ending   Twelve Months Ending
March 31, 2014 December 31, 2014
Low   High Low   High
Volume Point Growth vs 2013 6.5% 8.5% 6.5% 8.5%
Net Sales Growth vs 2013 8.0% 10.0% 7.5% 9.5%
Diluted EPS as adjusted $1.25 $1.29 $5.85 $6.05
Cap Ex ($ millions) $35.0 $45.0 $165.0 $185.0
Effective Tax Rate 27.5% 29.5% 28.0% 30.0%

Announces Quarterly Dividend

Herbalife reported today that its Board of Directors has approved a dividend of $0.30 per share to shareholders of record March 4, 2014, payable on March 18, 2014.

Fourth Quarter and Fiscal 2013 Earnings Conference Call

Herbalife senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Wednesday, February 19, 2013 at 8 a.m. PST (11 a.m. EST).

The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 31194371). Live audio of the conference call will be simultaneously webcast in the investor relations section of the Company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID 31194371). The webcast of the teleconference will be archived and available on Herbalife's website.

About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells weight-management, nutrition and personal care products intended to support a healthy lifestyle. Herbalife products are sold in more than 90 countries to and through a network of independent members. The Company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of financial and other information about the company at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.

1 See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for more detail.

2 Adjusted diluted EPS excludes non-cash interest expense associated with the company’s Convertible Notes.

3 There were no non-GAAP adjustments reported against the company’s 2012 fourth quarter or full-year U.S. GAAP results.

4 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com.

5 Worldwide Average Active Sales Leaders may not equal the sum of the Average Active Sales Leaders in each region due to the calculation being an average of Sales Leaders active in a period, not a summation, and the fact that some sales leaders are active in more than one region but are counted only once in the worldwide amount.

FORWARD-LOOKING STATEMENTS

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

RESULTS OF OPERATIONS:

Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)
               
Three Months Ended Twelve Months Ended
12/31/2013   12/31/2012 12/31/2013   12/31/2012
 
North America $ 210,302 $ 197,052 $ 907,999 $ 841,243
Mexico 142,599 132,070 562,369 496,101
South and Central America 290,344 203,252 973,456 688,799
EMEA 197,644 164,684 735,253 627,801
Asia Pacific 279,603 295,166 1,174,607 1,139,867
China   148,387   67,096   471,624   278,519
Worldwide net sales 1,268,879 1,059,320 4,825,308 4,072,330
Cost of Sales   251,807   211,105   963,423   812,583
Gross Profit 1,017,072 848,215 3,861,885 3,259,747
Royalty Overrides 380,735 355,658 1,497,556 1,338,633
Selling, General and Administrative Expenses   454,478   332,764   1,629,052   1,259,667
Operating Income 181,859 159,793 735,277 661,447
Interest Expense - net   2,902   2,453   18,560   10,541
Income before income taxes 178,957 157,340 716,717 650,906
Income Taxes   55,417   45,133   189,192   186,944
Net Income   123,540   112,207   527,525   463,962
 
Basic Shares 101,211 107,444 102,620 112,359
Diluted Shares 107,234 112,230 107,445 117,856
 
Basic EPS $ 1.22 $ 1.04 $ 5.14 $ 4.13
Diluted EPS $ 1.15 $ 1.00 $ 4.91 $ 3.94
 
Dividends declared per share $ 0.30 $ 0.30 $ 1.20 $ 1.20
 
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
  Dec 31,   Dec 31,
  2013     2012  
 
ASSETS
Current Assets:
Cash & cash equivalents $ 972,974 $ 333,534
Receivables, net 100,326 116,139
Inventories 351,201 339,411
Prepaid expenses and other current assets 148,774 145,624
Deferred income taxes   69,845     49,339  
Total Current Assets 1,643,120 984,047
 
Net Property, plant and equipment 318,860 242,886
Deferred compensation plan assets 26,821 24,267
Other assets 63,713 48,805
Deferred financing cost, net 4,896 7,462
Marketing related intangibles and other intangible assets, net 310,801 311,186
Goodwill   105,490     105,490  
Total Assets $ 2,473,701   $ 1,724,143  
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 82,665 $ 75,209
Royalty overrides 266,952 243,351
Accrued compensation 111,905 95,220
Accrued expenses 267,501 181,523
Current portion of long-term debt 81,250 56,302
Advance sales deposits 68,079 49,432
Income taxes payable   43,826     61,325  
Total Current Liabilities 922,178 762,362
 
Non-current liabilities
Long-term debt, net of current portion 850,019 431,305
Deferred compensation plan liability 37,226 29,454
Deferred income taxes 66,026 62,982
Other non-current liabilities   46,806     42,557  
Total Liabilities 1,922,255 1,328,660
 
Commitments and Contingencies
 
Shareholders' equity:
Common shares 101 107
Paid-in capital in excess of par value 323,860 303,975
Accumulated other comprehensive loss (19,794 ) (31,695 )
Retained earnings   247,279     123,096  
Total Shareholders' Equity   551,446     395,483  
   
Total Liabilities and Shareholders' Equity $ 2,473,701   $ 1,724,143  
 
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(In thousands)

(Unaudited)

 

   
Twelve Months Ended
  12/31/2013       12/31/2012  
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 527,525 $ 463,962

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization 84,739 74,384
Excess tax benefits from share-based payment arrangements (15,566 ) (29,684 )
Share based compensation expenses 29,492 27,906
Amortization of discount and deferred financing costs 2,579 1,797
Deferred income taxes (24,910 ) (7,758 )
Unrealized foreign exchange transaction loss (gain) 5,757 2,121
Foreign exchange loss from Venezuela currency devaluation 15,116 -
Other 15,410 532
Changes in operating assets and liabilities:
Receivables 9,224 (28,186 )
Inventories (39,878 ) (82,177 )
Prepaid expenses and other current assets (9,405 ) 249
Other assets (9,408 ) (5,288 )
Accounts payable 10,844 17,034
Royalty overrides 28,765 41,868
Accrued expenses and accrued compensation 86,039 39,440
Advance sales deposits 21,959 17,790
Income taxes 26,821 28,042
Deferred compensation plan liability   7,772     5,752  
NET CASH PROVIDED BY OPERATING ACTIVITIES   772,875     567,784  
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (146,958 ) (121,524 )
Proceeds from sale of property, plant and equipment 186 280
Investments in Venezuelan bonds (4,050 ) -
Deferred compensation plan assets   -     (3,756 )
NET CASH USED IN INVESTING ACTIVITIES   (150,822 )   (125,000 )
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid (123,055 ) (135,091 )
Borrowings from long-term debt 763,180 1,430,560
Principal payments on long-term debt (319,483 ) (1,146,580 )
Deferred financing costs - (4,460 )
Share repurchases (306,441 ) (556,727 )
Excess tax benefits from share-based payment arrangements 15,566 29,684

Proceeds from exercise of stock options and sale of stock under employee stock purchase plan

  975     11,373  
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   30,742     (371,241 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH   (13,355 )   3,216  
NET CHANGE IN CASH AND CASH EQUIVALENTS 639,440 74,759
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR   333,534     258,775  
CASH AND CASH EQUIVALENTS, END OF YEAR   972,974     333,534  
CASH PAID DURING THE YEAR
Interest paid $ 23,046   $ 14,268  
Income taxes paid $ 197,078   $ 169,725  
NON CASH ACTIVITIES
Accrued capital expenditures $ 29,625   $ 15,310  

SUPPLEMENTAL INFORMATION

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited and unreviewed), (dollars in thousands, except per share data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as “non-GAAP financial measures.” Management believes that such non-GAAP financial measures, when read in conjunction with the Company’s reported results, can provide useful supplemental information for investors in analyzing period to period comparisons of the Company’s results.

The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:

 
       
Three Months Ended Twelve Months Ended
12/31/2013 12/31/2012 12/31/2013 12/31/2012
(in thousands)
 
Net income, as reported $ 123,540 $ 112,207 $ 527,525 $ 463,962

Venezuela devaluation impact (net of ($1,442) and $5,354 tax benefit for the three and twelve months ended December 31, 2013, respectively) (1)(2)

1,442 - 9,761 -

Expenses incurred responding to attacks on the Company's business model (net of $1,372 and $4,613 tax benefit for the three and twelve months ended December 31, 2013, respectively)(1)

3,938 - 24,527 -

Expenses incurred for the re-audit of 2010 to 2012 financial statements due to resignation of KPMG (net of $2,524 and $4,853 tax benefit for the three and twelve months ended December 31, 2013)(1)

  8,269   -   15,570   -
Net income, as adjusted $ 137,189 $ 112,207 $ 577,383 $ 463,962
 
 
 

The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:

 
 
Three Months Ended Twelve Months Ended
12/31/2013 12/31/2012 12/31/2013 12/31/2012
 
Diluted earnings per share, as reported $ 1.15 $ 1.00 $ 4.91 $ 3.94

Venezuela devaluation impact (net of ($1,442) and $5,354 tax benefit for the three and twelve months ended December 31, 2013, respectively) (1)(2)

0.01 - 0.09 -

Expenses incurred responding to attacks on the Company's business model (net of $1,372 and $4,613 tax benefit for the three and twelve months ended December 31, 2013, respectively)(1)

0.04 - 0.23 -

Expenses incurred for the re-audit of 2010 to 2012 financial statements due to resignation of KPMG (net of $2,524 and $4,853 tax benefit for the three and twelve months ended December 31, 2013)(1)

  0.08   -   0.14   -
Diluted earnings per share, as adjusted $ 1.28 $ 1.00 $ 5.37 $ 3.94
 
 
 

(1) The income tax impact of the non-GAAP adjustments is based on items affecting the Company's 2013 full year GAAP effective tax rate. Adjustments to items unrelated to these non-GAAP adjustments have had an effect on the income tax impact of the non-GAAP adjustments in periods subsequent to the underlying non-GAAP adjustments.

(2) The amount for the three months ended December 31, 2013 relates to the change in tax benefit, as explained in note 1, for the Venezuela devaluation that was recorded in the first quarter.

The following is a reconciliation of total long-term debt to net debt:

    12/31/2013     12/31/2012
 
Total long-term debt (current and long-term portion) $ 931,269 $ 487,607
Less: Cash and cash equivalents   972,974     333,534
Net debt $ (41,705 ) $ 154,073

CONTACT:
Herbalife Ltd.
Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
213-745-0517
or
Investor Contact:
Amy Greene
VP, Investor Relations
213-745-0474